DrugDashboards

oseltamavir phosphate

oseltamavir phosphate · OSELTAMIVIR PHOSPHATE 45 mg/1 · Capsule · Oral · NuCare Pharmaceuticals, Inc.

NDC 68071-3741-01 · 1 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207211
TE code
AB
Approval date
Sep 14, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of oseltamavir phosphate (Capsule)

LabelerStrengthFirst seenLast seen
NuCare Pharmaceuticals, Inc.OSELTAMIVIR PHOSPHATE 45 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.OSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPOSELTAMIVIR PHOSPHATE 45 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPOSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "oseltamavir phosphate — NDC 68071-3741-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68071374101.

Free to cite with attribution — see how the data is put together.